NCT02246621 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- 150 milligrams (mg) Abemaciclib orally every 12 hours plus either 1 mg anastrozole or 2.5 mg letrozole orally once daily for 28 days (28 day cycles).
- id
- FG000
- title
- Abemaciclib + NSAI (Nonsteroidal Aromatase Inhibitors)
- description
- Placebo orally every 12 hours plus either 1 mg anastrozole or 2.5 mg letrozole orally once daily for 28 days (28 day cycles).
- id
- FG001
- title
- Placebo + NSAI
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 28
- group Id
- FG001
- num Subjects
- 16
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 236
- group Id
- FG001
- num Subjects
- 119
- type
- On Study Treatment/ Follow Up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 328
- group Id
- FG001
- num Subjects
- 165
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 327
- group Id
- FG001
- num Subjects
- 161
- type
- Received At Least One Dose of Study Drug
- achievements
- group Id
- FG000
- num Subjects
- 63
- group Id
- FG001
- num Subjects
- 30
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 265
- group Id
- FG001
- num Subjects
- 135
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Completers are participants who died.
Complete source fields
- groups
- description
- 150 milligrams (mg) Abemaciclib orally every 12 hours plus either 1 mg anastrozole or 2.5 mg letrozole orally once daily for 28 days (28 day cycles).
- id
- FG000
- title
- Abemaciclib + NSAI (Nonsteroidal Aromatase Inhibitors)
- description
- Placebo orally every 12 hours plus either 1 mg anastrozole or 2.5 mg letrozole orally once daily for 28 days (28 day cycles).
- id
- FG001
- title
- Placebo + NSAI
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 28
- group Id
- FG001
- num Subjects
- 16
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 236
- group Id
- FG001
- num Subjects
- 119
- type
- On Study Treatment/ Follow Up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 328
- group Id
- FG001
- num Subjects
- 165
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 327
- group Id
- FG001
- num Subjects
- 161
- type
- Received At Least One Dose of Study Drug
- achievements
- group Id
- FG000
- num Subjects
- 63
- group Id
- FG001
- num Subjects
- 30
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 265
- group Id
- FG001
- num Subjects
- 135
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Completers are participants who died.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle